MDisrupt

Genomic testing and molecular diagnostics have for a decades struggled to get sufficient payer coverage to get widespread adoption into routine healthcare. This is a great paper that explores some of the issues. At MDisrupt we have hundreds of payer executives willing to engage with the labs and manufacturers to help them navigate reimbursement. Payer expertise for genomic testing is currently one of our most requested services. https://lnkd.in/gU4cjCy7

As we close our 2024, Digital Health Executives share their biggest takeaways. Thank you Jessica Hagen and MobiHealthNews for featuring our CEO Ruby Gadelrab Tudor and our board member and investor Lisa Suennen, GCB.D "At MDisrupt, a key shift we’ve observed is that companies serious about disrupting healthcare are recognizing the value of healthcare insiders. This is particularly prevalent among second-time founders. They’re engaging clinicians, health system leaders and payor experts earlier in their product development process. This move ensures that solutions are more aligned with the realities of the healthcare system, making them more likely to succeed in scaling." "Women’s health has continued to grow as a focal point, with an inspiring wave of new companies addressing gaps in this space that are beyond fertility. However, funding opportunities remain disproportionately limited compared to the demand and innovation happening, signaling an ongoing need to advocate for equitable support in this critical are" https://lnkd.in/ge_hTSVK Other incredible leaders featured include Michael Howell, MD MPH, chief clinical officer at Google Roland Rott, president and CEO of imaging at GE HealthCare Mudit Garg, CEO and cofounder of Qventus, Inc Brooke Boyarsky Pratt, CEO and cofounder of knownwell Lisa Suennen, GCB.D, managing partner at American Heart Association Ventures Neil Patel, head of new ventures at Redesign Health Julia Bernstein, chief operations officer at Brightside Health Dan Nardi from Reimagine Care

🌟 Exciting Opportunity for an Experienced Internal Medicine or Family Medicine Physician! 🌟 Are you a dedicated clinician with a passion for personalized patient care, women’s health, and longevity medicine? We’re hiring a Medical Director for a fully-funded, premier concierge clinic located in West Los Angeles. Join a world-class leadership team and provide highly personalized, evidence-based care to a small panel of patients. This is a chance to shape the future of concierge medicine and collaborate with top experts in the field. ✨ Highlights: • 15+ years of clinical experience required. • Expertise in women’s health and longevity medicine. • Opportunity to contribute to research, community health, and medical education. • Competitive compensation, comprehensive benefits, and professional development. Be part of a mission to set a new standard of care! https://lnkd.in/giCNcEn2

Here is the hard truth about building a health product: skipping early feedback from healthcare insiders and payers can cost you YEARs of time and MILLIONS of $$$. At MDisrupt we are seeing a powerful shift. More and more companies are finally prioritizing feedback from real healthcare stakeholders - a critical step in the rush to scale. This isn't a nice to have, its the difference between products that SCALE and products that FAIL. So what are we doing about it? Today we are helping clients to: 👉🏼 Get feedback from PAYERS early on, crafting a reimbursement strategy that sets the stage for growth. 👉🏼 Consult CLINICIANS ensure products align seamlessly with clinical workflows — no more “great product, but hard to use” feedback. 👉🏼 Engage HEALTH SYSTEM LEADERS to confirm that the product addresses real, pressing clinical needs. We are making it as easy as possible to find these valuable experts and engage them in hourly calls so companies can get feedback quickly.

When the incredible Dr. Bayo C. visited us at #hlth to talk about the importance of having clinician voices as part of every healthcare innovation.

Many digital hypertension tools are costly, not effective: study from our friends at the Peterson Health Technology Institute (PHTI) https://lnkd.in/gYhicKTN

Our community of Experts, Clients, Investors and Supporters has grown so much this past year that we want to make sure we meet everyone at hlth! The MDisrupt team will be out in force at hlth and we will have a booth that you can stop by and visit us at. We can't wait to see you all! #hlth2024

We’re delighted to welcome Lisa Suennen, GCB.D, GCB.D, Managing Partner of American Heart Association Ventures, to the MDisrupt Board of Directors. Lisa brings a wealth of experience and expertise that will help ensure clinical and scientific rigor is applied to the development of every healthcare product. We look forward to the impact she will have as we continue driving innovation in healthcare.

We are delighted to share our big news this morning. The American Heart Association Ventures group has become a major investor in MDisrupt. We have also entered into a strategic collaboration to co-develop our expert marketplace with them to roll out to their thousands of scientific and clinical members. Finally incredible industry powerhouse and thought leader Lisa Suennen, GCB.D will be joining the board of MDisrupt https://lnkd.in/gFSNu8JY

Things are heating up in the early cancer detection space. https://lnkd.in/gDnYpGjS